FDA Inspection 1224590 — Molecular PharmaGroup LLC
The FDA completed an inspection of Molecular PharmaGroup LLC on Dec 11, 2023 in New Providence, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 11, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- New Providence, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 22779 | FDCA 503B(b)(2)(A) | All inclusive product report, not submitted |
| 22787 | FDCA 503B(a)(10)(A) | Drug product labels, fails to include |